Aft Pharmaceuticals Ltd (AFP.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 205,494 | 194,034 | 155,820 | 129,834 | 113,105 |
| Cost of Goods | 116,308 | 107,139 | 83,658 | 68,539 | 64,364 |
| Gross Profit | 89,186 | 86,895 | 72,162 | 61,295 | 48,741 |
| Operating Expenses | 77,487 | 66,578 | 55,038 | 42,655 | 39,763 |
| Operating Income | 11,699 | 20,317 | 17,124 | 18,640 | 8,978 |
| Interest Expense | 2,821 | 3,686 | 2,873 | 2,435 | 3,441 |
| Other Income | 7,156 | 5,388 | 1,548 | 2,480 | 2,350 |
| Pre-tax Income | 16,034 | 22,019 | 15,799 | 18,685 | 7,887 |
| Income Tax | 4,634 | 6,410 | 5,145 | -1,163 | 105 |
| Net Income Continuous | 11,400 | 15,609 | 10,654 | 19,848 | 7,782 |
| Minority Interests | 562 | N/A | N/A | N/A | N/A |
| Net Income | $11,962 | $15,609 | $10,654 | $19,848 | $7,782 |
| EPS Basic Total Ops | 0.11 | 0.15 | 0.10 | 0.19 | 0.08 |
| EPS Basic Continuous Ops | 0.11 | 0.15 | 0.10 | 0.19 | 0.08 |
| EPS Diluted Total Ops | 0.11 | 0.15 | 0.10 | 0.19 | 0.08 |
| EPS Diluted Continuous Ops | 0.11 | 0.15 | 0.10 | 0.19 | 0.08 |
| EBITDA(a) | $21,524 | $27,718 | $20,396 | $22,164 | $12,432 |